WFM
GILD icon

Wilmington Funds Management’s Gilead Sciences GILD Stock Holding History

Wilmington Funds Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$3.8M Buy
45,854
+7,983
+21% +$621K 0.38% 87
2014
Q1 		$2.68M Sell
37,871
-11,314
-23% -$887K 0.29% 106
2013
Q4 		$3.7M Sell
49,185
-8,239
-14% -$574K 0.37% 90
2013
Q3 		$3.61M Sell
57,424
-9,400
-14% -$562K 0.35% 103
2013
Q2 		$3.42M Buy
+66,824
New +$3.48M 0.32% 107

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wilmington Funds Management's GILD Position: Q2 2014 in Review

Wilmington Funds Management increased its Gilead Sciences (GILD) stake by 21% in Q2 2014, buying an estimated $621K and bringing the position to 45,854 shares worth $3.8M. The position accounts for 0.38% of the portfolio, ranked #87.

Wilmington Funds Management first reported a position in GILD in Q2 2013 and has held it in 5 quarters since. 1,263 funds tracked by Wall St. Rank hold GILD as of Q2 2014.

  • Wilmington Funds Management held 45,854 shares of Gilead Sciences worth $3.8M as of Q2 2014.
  • Wilmington Funds Management bought 7,983 Gilead Sciences shares in Q2 2014, an estimated $621K.
  • Gilead Sciences made up 0.38% of Wilmington Funds Management's portfolio in Q2 2014, its #87 holding.
  • Wilmington Funds Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 5 quarters since.
  • 1,263 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.